APPLIED CLINICAL TRIALS Issue Alert Having trouble viewing this email? Click here
Web Version | View Digital Edition | Subscribe
In our September/October issue:

FEATURED
Collaborative R&D: Doing it Right
Expert perspectives on effective partnering in today's new era of collaboration, including the role of technology and strategies to de-risk alliance arrangements from the get-go.

PEER-REVIEWED ARTICLES

 Reducing Supply Chain Risk
Chad Presher, Adam Sheriff, Lorna Briddick
Ensuring the supply of clinical drugs during times of crisis is a necessary moral and ethical obligation. Authors present a decision-making framework that integrates real-world signals with supply planning techniques to mitigate risk and avoid potential supply interruptions.
Temperature Control in Transit
Richard Segiel
Comprehensive and compliant monitoring of temperature-sensitive material is critical throughout the transport of investigational drugs to sites. Report explores how a single-source temperature management strategy can support a product's quality and integrity from origin to destination.
NEWS
Washington Report: Jill Wechsler on FDA's growing acceptance of real-world data in clinical decision-making.

EU Report: Peter O'Donnell looks at the broader quality debate stemming from EMA's new safety review of valproate.

Global Report: Philip Ward details the latest entrant into Europe's bidding war for the EMA post-Brexit.

Q&A: Discussion highlights the evolution of the patient-centric supply chain and its potential impact on the clinical trials landscape.

LIFECYCLE MANAGEMENT: The new challenges for pharmacovigilance experts in Europe, where interpretation of data is now key.

TRIAL MANAGEMENT: Examining the supply chain complexities in Latin America and strategies to overcome regulatory and import hurdles.

CLINICAL TRIAL INSIGHTS
Debunking HCP Disengagement
Ken Getz
Contrary to perception, study finds that healthcare providers are positioned as patient engagement facilitators for clinical trials—if equipped to advocate on patients' behalf.
CLOSING THOUGHT

Automation and Cell Therapy
Rolf Ehrhardt
For cell therapies to be successful, the use of automation tools to boost efficiency and mitigate risk during production and delivery will be critical.

Download the
issue:
image
 
BLOGS
Clinical Trials Confusing—Even to Doctors
New mHealth Action Plan Released
A Look Into FDA's Digital Health Action Plan
WEBCAST
Rare Diseases and the Eye: Strategies for Success
Developing drugs for rare ophthalmologic disorders present unique challenges, but with those challenges come opportunities to explore innovative strategies to achieve clinical trial success. Learn about such approaches in treating rare eye conditions.

If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - lisa.henderson@ubm.com

Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.

Click here to contact the Applied Clinical Trials sales team.
Twitter LinkedIn